FeverAll® Acetaminophen Suppositories Expands with New Publix Distribution

Wednesday, January 8, 2020 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Just in Time for 2020's Severe Flu Season, Taro USA Expands Distribution for its FeverAll Children's Fever and Pain Relief Brand

HAWTHORNE, N.Y., Jan. 7, 2020 /PRNewswire-PRWeb/ -- FeverAll®, the #1 doctor and Mommy MD Guides recommended brand of acetaminophen suppositories for children as young as six months of age, has expanded its distribution to Publix. The FeverAll Infants' Strength (80 mg of acetaminophen) for the temporary reduction of fever, pain and headaches, is available just in time for this cold and flu season, which is proving to be severe.

"Despite the range of severity of the cold/flu seasons the last several years, the FeverAll brand has been growing steadily, gaining new distribution at several retailers, including Publix and Target, and thriving at longstanding retailers," says Phil Tucker, director of OTC sales at Taro Pharmaceuticals U.S.A., Inc. "We believe this is due to the fact that we have been raising awareness of some of FeverAll's unique qualities, such as the measured dosing and our 'pure medicine' formula free of parabens, dyes and sugars often found in oral liquid medications."

A survey conducted by Taro USA of more than 400 pediatric nurse practitioners (PNPs) at the annual National Association of Pediatric Nurse Practitioners (NAPNAP) conference in March 2019, found that more than 3/4s of PNPs have patients looking for products with less inactive ingredients and premeasured dosing.

"FeverAll suppositories have the fewest inactive ingredients than the leading acetaminophen oral liquid brand,*" explains Tucker. "FeverAll has no high fructose corn syrup, parabens, artificial colors and preservatives or alcohol – all ingredients that are concerning to parents and healthcare providers, and unnecessary for children."

In addition, the small suppository form ensures accurate dosing every time so there is no need for measuring, plus it's the recommended way to dose acetaminophen if a child is unable to take oral liquid medicine as a result of vomiting, spitting out or if unwilling to take oral liquid acetaminophen.

To learn more information about FeverAll® Acetaminophen Suppositories and see the list of retailers, visit http://www.feverall.com.

About Taro Pharmaceutical Industries Ltd. Taro was founded in 1988 and is based in Hawthorne, New York. Taro Pharmaceuticals U.S.A., Inc. operates as a subsidiary of Taro Pharmaceutical Industries Ltd. Taro is a research-based international pharmaceutical company that was established on the principal that research and development would be the cornerstone of its growth strategy. Providing quality products through scientific innovations, diligence and precision is the goal of all of Taro's research programs. Taro develops high-quality, proprietary and off-patent pharmaceuticals for markets in the US, Canada, Israel and other countries around the world. The Company produces a wide range of prescription and over-the counter products including FeverAll® Acetaminophen Suppositories, tablets, capsules, suspensions, solutions, creams, and ointments.

*Versus infants' Tylenol acetaminophen oral suspension

 

SOURCE FeverAll



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store